Cargando…
The role of Interactive Binocular Treatment system in amblyopia therapy
PURPOSE: To determine the role of Interactive Binocular Treatment (I-BiT™) as a complementary method of patching in amblyopia therapy. METHODS: In this randomized clinical trial study, 50 unilateral amblyopic children (25 male/25 female) between 3 and 10 years with either best corrected visual acuit...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093783/ https://www.ncbi.nlm.nih.gov/pubmed/27830207 http://dx.doi.org/10.1016/j.joco.2016.07.005 |
_version_ | 1782465000959377408 |
---|---|
author | Rajavi, Zhale Sabbaghi, Hamideh Amini Sharifi, Ebrahim Behradfar, Narges Yaseri, Mehdi |
author_facet | Rajavi, Zhale Sabbaghi, Hamideh Amini Sharifi, Ebrahim Behradfar, Narges Yaseri, Mehdi |
author_sort | Rajavi, Zhale |
collection | PubMed |
description | PURPOSE: To determine the role of Interactive Binocular Treatment (I-BiT™) as a complementary method of patching in amblyopia therapy. METHODS: In this randomized clinical trial study, 50 unilateral amblyopic children (25 male/25 female) between 3 and 10 years with either best corrected visual acuity (BCVA) ≤20/30 in the amblyopic eye or a difference of BCVA ≥ 2 lines between the two eyes were included. They were randomly classified into the case and control groups (25 in each). Patching was recommended in both groups, and cases also received I-BiT™. Cases were asked to play I-BiT™ games through appropriate glasses with conjugate colored filters. Moving and fixed targets were shown to the amblyopic and non-amblyopic eyes, respectively. Playing games was continued 20 min in each session for 5 days a week within one month (total time: 6.6 h). Patching was continued for one month more in both groups to evaluate the continuous effect of I-BiT™. BCVA was measured at baseline, one month after beginning I-BiT™, and one month after cessation of I-BiT™. RESULTS: BCVA of amblyopic eyes in cases and controls were 0.34 ± 0.14 and 0.33 ± 0.17LogMAR at baseline which improved to 0.17 ± 0.14 and 0.26 ± 0.17 at one month, respectively. The difference was significant in each group (p < 0.001 for cases and p = 0.024 for controls) with more improvement in the case group (p < 0.001). One month after cessation of I-BiT™, BCVA difference between the two groups was not statistically significant. There was no case with recurrence of amblyopia. CONCLUSION: Based on our results, I-BiT™ seems to be effective in amblyopia therapy accompanied with patching. We recommend comparing I-BiT™ alone with patching in further studies. ClinicalTrials.gov Identifier: NCT02740725. |
format | Online Article Text |
id | pubmed-5093783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-50937832016-11-09 The role of Interactive Binocular Treatment system in amblyopia therapy Rajavi, Zhale Sabbaghi, Hamideh Amini Sharifi, Ebrahim Behradfar, Narges Yaseri, Mehdi J Curr Ophthalmol Original Research PURPOSE: To determine the role of Interactive Binocular Treatment (I-BiT™) as a complementary method of patching in amblyopia therapy. METHODS: In this randomized clinical trial study, 50 unilateral amblyopic children (25 male/25 female) between 3 and 10 years with either best corrected visual acuity (BCVA) ≤20/30 in the amblyopic eye or a difference of BCVA ≥ 2 lines between the two eyes were included. They were randomly classified into the case and control groups (25 in each). Patching was recommended in both groups, and cases also received I-BiT™. Cases were asked to play I-BiT™ games through appropriate glasses with conjugate colored filters. Moving and fixed targets were shown to the amblyopic and non-amblyopic eyes, respectively. Playing games was continued 20 min in each session for 5 days a week within one month (total time: 6.6 h). Patching was continued for one month more in both groups to evaluate the continuous effect of I-BiT™. BCVA was measured at baseline, one month after beginning I-BiT™, and one month after cessation of I-BiT™. RESULTS: BCVA of amblyopic eyes in cases and controls were 0.34 ± 0.14 and 0.33 ± 0.17LogMAR at baseline which improved to 0.17 ± 0.14 and 0.26 ± 0.17 at one month, respectively. The difference was significant in each group (p < 0.001 for cases and p = 0.024 for controls) with more improvement in the case group (p < 0.001). One month after cessation of I-BiT™, BCVA difference between the two groups was not statistically significant. There was no case with recurrence of amblyopia. CONCLUSION: Based on our results, I-BiT™ seems to be effective in amblyopia therapy accompanied with patching. We recommend comparing I-BiT™ alone with patching in further studies. ClinicalTrials.gov Identifier: NCT02740725. Elsevier 2016-08-09 /pmc/articles/PMC5093783/ /pubmed/27830207 http://dx.doi.org/10.1016/j.joco.2016.07.005 Text en © 2016, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Rajavi, Zhale Sabbaghi, Hamideh Amini Sharifi, Ebrahim Behradfar, Narges Yaseri, Mehdi The role of Interactive Binocular Treatment system in amblyopia therapy |
title | The role of Interactive Binocular Treatment system in amblyopia therapy |
title_full | The role of Interactive Binocular Treatment system in amblyopia therapy |
title_fullStr | The role of Interactive Binocular Treatment system in amblyopia therapy |
title_full_unstemmed | The role of Interactive Binocular Treatment system in amblyopia therapy |
title_short | The role of Interactive Binocular Treatment system in amblyopia therapy |
title_sort | role of interactive binocular treatment system in amblyopia therapy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093783/ https://www.ncbi.nlm.nih.gov/pubmed/27830207 http://dx.doi.org/10.1016/j.joco.2016.07.005 |
work_keys_str_mv | AT rajavizhale theroleofinteractivebinoculartreatmentsysteminamblyopiatherapy AT sabbaghihamideh theroleofinteractivebinoculartreatmentsysteminamblyopiatherapy AT aminisharifiebrahim theroleofinteractivebinoculartreatmentsysteminamblyopiatherapy AT behradfarnarges theroleofinteractivebinoculartreatmentsysteminamblyopiatherapy AT yaserimehdi theroleofinteractivebinoculartreatmentsysteminamblyopiatherapy AT rajavizhale roleofinteractivebinoculartreatmentsysteminamblyopiatherapy AT sabbaghihamideh roleofinteractivebinoculartreatmentsysteminamblyopiatherapy AT aminisharifiebrahim roleofinteractivebinoculartreatmentsysteminamblyopiatherapy AT behradfarnarges roleofinteractivebinoculartreatmentsysteminamblyopiatherapy AT yaserimehdi roleofinteractivebinoculartreatmentsysteminamblyopiatherapy |